Wanbury Ltd
WANBURYWanbury Ltd
WANBURY
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 36.95 | -11.05 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.46 | 5.11 | 0.70% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Wanbury Limited is a pharmaceutical company which offers active pharmaceutical ingredient in over 70 countries.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 256.40 | 424.66 | 523.49 | 447.80 | 400.70 | 451.23 | 394.92 | 589.07 | 500.56 | 549.07 | ||||||||||
Raw Materials | 116.45 | 182.15 | 191.12 | 166.40 | 201.26 | 169.75 | 228.53 | 325.07 | 273.46 | 498.79 | ||||||||||
| Power & Fuel Cost | 10.05 | 18.51 | 18.74 | 15.26 | 14.46 | 15.38 | 17.13 | 18.41 | 20.59 | |||||||||||
| Employee Cost | 39.63 | 85.59 | 87.77 | 87.32 | 75.89 | 67.48 | 64.15 | 74.81 | 81.00 | |||||||||||
| Selling & Administrative Expenses | 40.28 | 70.43 | 76.62 | 64.45 | 63.70 | 55.36 | 45.49 | 55.13 | 46.01 | |||||||||||
| Operating & Other expenses | 22.09 | 34.22 | 41.03 | 105.59 | 20.52 | 36.04 | 19.20 | 2.44 | 56.01 | |||||||||||
EBITDA | 27.90 | 33.76 | 108.21 | 8.78 | 24.87 | 107.22 | 20.42 | 113.21 | 23.49 | 50.28 | ||||||||||
| Depreciation/Amortization | 4.80 | 9.05 | 10.32 | 10.30 | 9.97 | 9.68 | 9.75 | 11.45 | 12.38 | 12.62 | ||||||||||
| PBIT | 23.10 | 24.71 | 97.89 | -1.52 | 14.90 | 97.54 | 10.67 | 101.76 | 11.11 | 37.66 | ||||||||||
| Interest & Other Items | 18.62 | 31.87 | 35.51 | 30.86 | 39.88 | 32.87 | 23.07 | 20.61 | 21.39 | 27.60 | ||||||||||
| PBT | 4.48 | -7.16 | 62.38 | -32.38 | -24.98 | 64.67 | -12.40 | 81.15 | -10.28 | 10.06 | ||||||||||
| Taxes & Other Items | 1.27 | 0.00 | 0.39 | -0.38 | -0.14 | 0.21 | 0.20 | -0.35 | 0.11 | 0.25 | ||||||||||
| Net Income | 3.21 | -7.16 | 61.99 | -32.00 | -24.84 | 64.46 | -12.60 | 81.50 | -10.39 | 9.81 | ||||||||||
| EPS | 1.61 | -3.59 | 28.71 | -13.63 | -10.47 | 26.46 | -5.04 | 28.26 | -3.18 | 3.00 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Wanbury Ltd | -34.89 | -11.05 | — |
| Sun Pharmaceutical Industries Ltd | 35.10 | 5.01 | 0.93% |
| Cipla Ltd | 35.28 | 4.17 | 0.69% |
| Dr Reddy's Laboratories Ltd | 21.34 | 4.13 | 0.69% |
Price Comparison
Compare WANBURY with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
High Pledged Promoter Holding
A significant proportion of promoter holdings is pledged
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
WANBURY has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJul 29, 2010
Dividend/Share
₹1.00
Ex DateEx Date
Jul 29, 2010
News & Opinions
Wanbury Consolidated June 2023 Net Sales at Rs 146.29 crore, up 25.09% Y-o-Y
3 months ago•Moneycontrol
Stocks In Focus: Adani, Indian Hotels, Lupin, Kalpataru, in news Today
4 months ago•The Hindu Businessline
Wanbury Consolidated September 2022 Net Sales at Rs 123.96 crore, down 0.11% Y-o-Y
1 year ago•Moneycontrol
Wanbury Standalone September 2022 Net Sales at Rs 123.96 crore, down 0.11% Y-o-Y
1 year ago•Moneycontrol
Wanbury reports consolidated net profit of Rs 82.54 crore in the March 2022 quarter
1 year ago•Business Standard
Stocks that will see action today: Feb 18
1 year ago•The Hindu Businessline
Wanbury Consolidated December 2021 Net Sales at Rs 124.84 crore, up 13.8% Y-o-Y
1 year ago•Moneycontrol
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 2.25%, vs industry avg of 8.45%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.22% to 0.16%